FindTrial
Sign In

Direct Acting Antivirals

DRUG10 trials

Sponsors

Kaiser Permanente, Post Graduate Institute of Medical Education and Research, Chandigarh, University of Maryland, Baltimore, Assiut University, Massachusetts General Hospital

Conditions

Carcinoma, HepatocellularChronic Hepatitis cDirect Acting Antiviral AgentsDrug EffectDrug Side EffectHepatitis CHepatitis C Virus Infection, Response to Therapy ofHepatitis C, Chronic

Early Phase 1

Hepatitis C Positive Donor Into Hepatitis C Negative Recipients
WithdrawnNCT03702218
University of Maryland, BaltimoreHepatitis C
Start: 2019-07-01End: 2019-07-01Updated: 2023-05-06

Phase 4

HCV + to HCV - Kidney Transplant
WithdrawnNCT04320290
Massachusetts General HospitalHepatitis C, Kidney Failure
Start: 2020-05-21End: 2020-06-16Updated: 2022-08-31

Unknown Phase

An Observational Study of the Safety of Direct-acting Antivirals in Patients With Hepatitis C
CompletedNCT03423641
Kaiser PermanenteHepatitis C, Chronic
Start: 2011-01-01End: 2017-12-31Updated: 2019-08-07
DAA Therapy in Pediatric Patients With Chronic Hepatitis C
NCT03481036
Post Graduate Institute of Medical Education and Research, ChandigarhChronic Hepatitis c
Start: 2016-06-18End: 2020-12-31Target: 100Updated: 2019-06-17
Management of Patients With Hepatitis C in a Public Health Care Setting: The Punjab Model
NCT03488485
Post Graduate Institute of Medical Education and Research, ChandigarhChronic Hepatitis c
Start: 2016-06-18End: 2020-12-31Target: 50000Updated: 2019-06-14
Frequency of Anxiety and Depression in Chronic Hepatitis C Patients Recieving Direct-Acting Antiviral Agents
NCT03894696
Assiut UniversityChronic Hepatitis c
Start: 2019-08-01End: 2020-05-01Target: 200Updated: 2019-07-08
HCV RAS Testing in Public Health Programs
NCT04242433
Post Graduate Institute of Medical Education and Research, ChandigarhDirect Acting Antiviral Agents, Hepatitis C, Public Health +1
Start: 2017-07-16End: 2021-08-31Target: 200Updated: 2020-01-27
The Treatment in Pregnancy for Hepatitis C (TiP-HepC) Registry
RecruitingNCT05368974
The Task Force for Global HealthHepatitis C
Start: 2022-02-11End: 2026-12-30Target: 100Updated: 2024-12-18
Treatment of Hepatitis c by Using Direct-acting Antiviral
NCT05372874
Tanta UniversityHepatitis C
Start: 2022-05-06End: 2022-07-30Target: 50Updated: 2022-05-13
Possible Differences in HCC Course Depending on DAA Treatment
NCT05376943
Medical University of WarsawCarcinoma, Hepatocellular, Drug Effect, Drug Side Effect +3
Start: 2022-05-10End: 2022-12-31Target: 100Updated: 2022-05-17

Related Papers

Impact of Resistance Associated Substitutions and Predictors of Treatment Failure Following Direct-acting Antiviral Therapy in a Viral Hepatitis C Elimination Cohort.
2025-05-281 citations
Recompensation of Chronic Hepatitis C-Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program.
2024-08-2321 citations
Outcomes of Real-World Integrated HCV Microelimination for People Who Inject Drugs: An expansion of the Punjab Model.
2021-10-1718 citations